81 reports of this reaction
7.2% of all MOMETASONE FUROATE MONOHYDRATE reports
#1 most reported adverse reaction
DEATH is the #1 most commonly reported adverse reaction for MOMETASONE FUROATE MONOHYDRATE, manufactured by CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED. There are 81 FDA adverse event reports linking MOMETASONE FUROATE MONOHYDRATE to DEATH. This represents approximately 7.2% of all 1,126 adverse event reports for this drug.
Patients taking MOMETASONE FUROATE MONOHYDRATE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is moderately reported among MOMETASONE FUROATE MONOHYDRATE users, representing a notable but not dominant share of adverse events.
In addition to death, the following adverse reactions have been reported for MOMETASONE FUROATE MONOHYDRATE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 81 FDA reports for MOMETASONE FUROATE MONOHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 7.2% of all adverse event reports for MOMETASONE FUROATE MONOHYDRATE, making it one of the most commonly reported side effect.
If you experience death while taking MOMETASONE FUROATE MONOHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.